Determinants of variations in initial treatment strategies for stable ischemic heart disease

Maria C Bennell1, Feng Qiu1, Kori J Kingsbury1

  • 1Schulich Heart Centre (Bennell, Wijeysundera), Division of Cardiology, Sunnybrook Health Sciences Centre, University of Toronto; the Institute of Health Policy, Management and Evaluation (Austin, Wijeysundera), University of Toronto; the Institute for Clinical Evaluative Sciences (Qiu, Austin, Wijeysundera); the Cardiac Care Network of Ontario (Kingsbury), Toronto, Ont.

Insights

Hospital treatment ratios for stable ischemic heart disease vary, driven mainly by patient factors. Higher revascularization ratios were linked to increased patient mortality, suggesting a need for outcome-based care optimization.

Area of Science:

  • Cardiology
  • Health Services Research
  • Clinical Outcomes

Background:

  • Significant variation exists in revascularization ratios for stable ischemic heart disease treatment across hospitals.
  • A study investigated patient, physician, and hospital factors influencing these ratios.
  • The research also examined clinical outcomes associated with varying revascularization rates.

Purpose of the Study:

  • To identify factors contributing to the variability in revascularization ratios among Ontario cardiac centers.
  • To determine if clinical outcomes, specifically mortality, differ between hospitals with high, medium, and low revascularization ratios.

Main Methods:

  • Analysis of patients with stable ischemic heart disease undergoing angiography in Ontario (2008-2011).
  • Hospitals categorized into tertiles based on their revascularization ratio.
  • Hierarchical logistic regression and multivariable Cox proportional hazards models used to assess predictors and outcomes.

Main Results:

  • Revascularization ratios varied twofold across hospitals, primarily explained by patient factors (67.4%).
  • Patient predictors included smoking history, multivessel disease, high-risk stress tests, and severe angina.
  • Higher revascularization ratios correlated with increased all-cause mortality (HR 1.12).

Conclusions:

  • Most variation in revascularization ratios is attributable to patient-specific factors.
  • Despite patient-driven variation, differences in hospital revascularization ratios are associated with significant variations in mortality.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
602
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
439
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
487
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
530
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K